Avanos Medical, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
-403.00
-7.00
26.00
7.00
-60.00
-64.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-4.00
-40.00
-24.00
21.00
-54.00
-59.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
100.00
32.00
90.00
87.00
-2.00
-74.00
Cash Flow from Investing Activities
-27.00
21.00
-135.00
-21.00
-24.00
-108.00
Cash Flow from Financing Activities
-49.00
-94.00
56.00
-55.00
-70.00
1.00
Net Cash Inflow / Outflow
20.00
-40.00
9.00
7.00
-93.00
-179.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-4.00
0.00
-3.00
-4.00
2.00
1.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Avanos Medical, Inc.
Figures in Million
consolidated Cash Flow Results
Change(USD)
Change(%)
Profit Before Tax
-403.3
-53.48
-350.00
-654.11%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-4.4
-15.463
11.00
71.54%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
100.7
-27.166
127.00
470.68%
Cash Flow from Investing Activities
-27.5
-15.685
-12.00
-75.33%
Cash Flow from Financing Activities
-49.1
0.311
-49.00
-15887.78%
Net Cash Inflow / Outflow
20
-41.059
61.00
148.71%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-4.1
1.481
-5.00
-376.84%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 210.80% vs -64.36% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
100.70
32.40
210.80%






